Somite.ai is developing AI foundation models for human stem cells to drive novel cell therapies at scale. We take a full-stack approach—generating data at 1,000x lower cost, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy.
Our founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT (pioneered the foundational research on scaling laws), and four Harvard Medical School professors and National Academy of Sciences/Medicine members, including the Chair of the Genetics Department at HMS. Based in Boston and launching operations in January 2024, Somite has raised over $11M in pre-seed funding
Company Details
- Employees
- 40
- Founded
- -
- Address
- 240 Longwood Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://somite.ai/
- Keywords
- Manager jobs.
- HQ
- Boston, Massachusetts
Somite Ai Questions
Somite Ai's website is https://somite.ai/
Somite Ai's LinkedIn profile is https://www.linkedin.com/company/somite-therapeutics
Somite Ai has
40 employees.
View email and phone details for 40
employees at Somite Ai.
Somite Ai's industry is
Biotechnology Research
Somite Ai's top competitors are
Phasev,
Leafix Medical,
Stylus Medicine,
Chorus By Zoominfo,
Restore Medical,
Omniabio,
4m Analytics,
Immunai,
Neuralight,
Guardoc Health.
Somite Ai's categories are Biotechnology Research
Somite Ai's founding year is 2023
